Farmers National Banc Corp director Terry Moore on the 04/01/2018 bought a total of 226 shares of the public firm with market value around $3,336 U.S Dollars. This is based on an average price per share of $14.8 U.S Dollars. Terry is trying to silently increase his company’s share, same as he did in the last month. He obtained another 224 shares worth $3,331 USD. Dated 04/01/2018 the transaction Form 4 is ready for review here. Today, Terry Moore owns 58,884 shares which are roughly 0.21% of the company’s market cap (total dollar market value of all company’s outstanding shares).
Bristol-Myers Squibb Company discovers, develops, licenses, makes, markets, and distributes biopharmaceutical products worldwide. The company has market cap of $100.88 billion. The firm offers chemically-synthesized drug and biologic in various therapeutic areas, such as oncology; cardiovascular; immunoscience; and virology comprising human immunodeficiency virus infection . It has a 24.18 P/E ratio. The Company’s products include Empliciti, a humanized monoclonal antibody to treat multiple myeloma; Opdivo, a human monoclonal antibody to treat renal cell carcinoma, non-small cell lung cancer, classical Hodgkin lymphoma, gastric cancer, melanoma, metastatic urothelial carcinoma, and squamous cell carcinoma of the head and neck; Erbitux, an IgG1 monoclonal antibody that blocks the epidermal growth factor receptor; Sprycel, a tyrosine kinase inhibitor for the treatment of adults with Philadelphia chromosome-positive chronic myeloid leukemia; and Yervoy, a monoclonal antibody for metastatic melanoma.
Farmers National Banc Corp., through its subsidiaries, operates in the banking, trust, retirement consulting, insurance, and financial management industries. The company has market cap of $413.16 million. The firm offers commercial and retail banking services, including checking, savings, and time deposit accounts; commercial, mortgage and installment, and home equity loans; home equity lines of credit; and night depository, safe deposit box, money order, bank check, automated teller machine, Internet banking, travel card, E bond transaction, credit card, and brokerage and other services. It has a 17.99 P/E ratio. It also provides personal and corporate trust services in the areas of estate settlement, trust administration, and employee benefit plans; retirement services; and various insurance products through licensed representatives, as well as invests in municipal securities.
Among 3 analysts covering Farmers National Banc Corp (NASDAQ:FMNB), 0 have Buy rating, 0 Sell and 3 Hold. Therefore 0 are positive. Farmers National Banc Corp has $17.0 highest and $9.75 lowest target. $13.50’s average target is -10.00% below currents $15 stock price. Farmers National Banc Corp had 10 analyst reports since September 22, 2015 according to SRatingsIntel. On Friday, October 27 the stock rating was downgraded by Wood to “Market Perform”. The stock has “Buy” rating by Keefe Bruyette & Woods on Tuesday, October 3. The stock of Farmers National Banc Corp. (NASDAQ:FMNB) earned “Buy” rating by Keefe Bruyette & Woods on Wednesday, August 30. The stock of Farmers National Banc Corp. (NASDAQ:FMNB) has “Mkt Perform” rating given on Friday, December 16 by Raymond James. The stock of Farmers National Banc Corp. (NASDAQ:FMNB) earned “Hold” rating by Keefe Bruyette & Woods on Thursday, December 21. Keefe Bruyette & Woods initiated the stock with “Outperform” rating in Tuesday, September 22 report. Raymond James initiated the shares of FMNB in report on Thursday, January 14 with “Outperform” rating. The firm has “Hold” rating given on Friday, October 27 by Keefe Bruyette & Woods. On Monday, June 26 the stock rating was maintained by Keefe Bruyette & Woods with “Buy”.
Analysts await Farmers National Banc Corp. (NASDAQ:FMNB) to report earnings on January, 24. They expect $0.23 EPS, up 15.00% or $0.03 from last year’s $0.2 per share. FMNB’s profit will be $6.34M for 16.30 P/E if the $0.23 EPS becomes a reality. After $0.23 actual EPS reported by Farmers National Banc Corp. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.
The stock increased 3.09% or $0.45 during the last trading session, reaching $15. About 9,380 shares traded. Farmers National Banc Corp. (NASDAQ:FMNB) has risen 47.67% since January 4, 2017 and is uptrending. It has outperformed by 30.97% the S&P500.
Investors sentiment increased to 1.34 in 2017 Q3. Its up 0.06, from 1.28 in 2017Q2. It is positive, as 6 investors sold Farmers National Banc Corp. shares while 26 reduced holdings. 11 funds opened positions while 32 raised stakes. 9.53 million shares or 2.29% more from 9.31 million shares in 2017Q2 were reported. Investment Partners Ltd Oh Adv, Ohio-based fund reported 168,081 shares. Voya Investment Management Limited owns 21,540 shares. Vanguard Gp Incorporated owns 986,688 shares. Commercial Bank Of New York Mellon Corporation invested in 0% or 91,303 shares. Royal Commercial Bank Of Canada reported 2,289 shares or 0% of all its holdings. Clarivest Asset Limited Liability Company stated it has 0.01% in Farmers National Banc Corp. (NASDAQ:FMNB). California State Teachers Retirement System owns 40,724 shares or 0% of their US portfolio. Moreover, Wells Fargo & Mn has 0% invested in Farmers National Banc Corp. (NASDAQ:FMNB) for 30,227 shares. Pnc Fincl Group Inc Inc holds 0% of its portfolio in Farmers National Banc Corp. (NASDAQ:FMNB) for 74,545 shares. Federated Investors Pa owns 209 shares. Sg Americas Ltd Liability Company stated it has 10,994 shares or 0% of all its holdings. Rhumbline Advisers stated it has 26,960 shares. Illinois-based Banc Funds Limited Co has invested 0.2% in Farmers National Banc Corp. (NASDAQ:FMNB). Ameritas Inv Ptnrs Inc holds 0% or 1,937 shares. Stifel reported 13,244 shares stake.
Terril Brothers Inc. holds 10.38% of its portfolio in Bristol-Myers Squibb Company for 508,489 shares. Blackhill Capital Inc owns 466,195 shares or 5.58% of their US portfolio. Moreover, Opus Point Partners Management Llc has 5.15% invested in the company for 90,000 shares. The North Carolina-based Westend Advisors Llc has invested 4.92% in the stock. Benchmark Capital Advisors, a New York-based fund reported 98,034 shares.
Ratings analysis reveals 33% of Bristol-Myers Squibb Co’s analysts are positive. Out of 3 Wall Street analysts rating Bristol-Myers Squibb Co, 1 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. The lowest target is $52.0 while the high is $70. The stock’s average target of $62.33 is 1.13% above today’s ($61.635) share price. BMY was included in 4 notes of analysts from November 18, 2015. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Buy” rating by Jefferies on Monday, December 19. On Friday, October 28 the stock rating was maintained by Deutsche Bank with “Hold”. The firm has “Equal Weight” rating given on Friday, September 9 by Barclays Capital.
Since January 1, 0001, it had 1 buying transaction, and 2 selling transactions for $646,385 activity.